Relmada Therapeutics (RLMD) Shareholding Patterns
$4.49
As on 01-Sep-2026 13:37EDT
Market cap
$462 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.3
Div. Yield
0 %
$4.49
As on 01-Sep-2026 13:37EDT
Market cap
$462 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.3
Div. Yield
0 %